Format
Sort by

Send to

Choose Destination

Links from PubMed

Items: 18

1.

Development of an adverse drug reaction risk assessment score among hospitalized patients with chronic kidney disease.

Sharif-Askari FS, Syed Sulaiman SA, Saheb Sharif-Askari N, Al Sayed Hussain A.

PLoS One. 2014 Apr 22;9(4):e95991. doi: 10.1371/journal.pone.0095991.

2.
3.

Effects of pharmacists' interventions on appropriateness of prescribing and evaluation of the instruments' (MAI, STOPP and STARTs') ability to predict hospitalization--analyses from a randomized controlled trial.

Gillespie U, Alassaad A, Hammarlund-Udenaes M, Mörlin C, Henrohn D, Bertilsson M, Melhus H.

PLoS One. 2013 May 17;8(5):e62401. doi: 10.1371/journal.pone.0062401.

4.

Drug-related emergency department visits by elderly patients presenting with non-specific complaints.

Nickel CH, Ruedinger JM, Messmer AS, Maile S, Peng A, Bodmer M, Kressig RW, Kraehenbuehl S, Bingisser R.

Scand J Trauma Resusc Emerg Med. 2013 Mar 5;21:15. doi: 10.1186/1757-7241-21-15.

5.

The effect of community pharmacy-based interventions on patient health outcomes: a systematic review.

Blalock SJ, Roberts AW, Lauffenburger JC, Thompson T, O'Connor SK.

Med Care Res Rev. 2013 Jun;70(3):235-66. doi: 10.1177/1077558712459215. Review.

6.

Underrepresentation of elderly people in randomised controlled trials. The example of trials of 4 widely prescribed drugs.

Konrat C, Boutron I, Trinquart L, Auleley GR, Ricordeau P, Ravaud P.

PLoS One. 2012;7(3):e33559. doi: 10.1371/journal.pone.0033559.

7.
8.

Qualitative insights into general practitioners views on polypharmacy.

Anthierens S, Tansens A, Petrovic M, Christiaens T.

BMC Fam Pract. 2010 Sep 15;11:65. doi: 10.1186/1471-2296-11-65.

9.

Primary care clinicians' experiences with treatment decision making for older persons with multiple conditions.

Fried TR, Tinetti ME, Iannone L.

Arch Intern Med. 2011 Jan 10;171(1):75-80. doi: 10.1001/archinternmed.2010.318.

10.

An unintended consequence of electronic prescriptions: prevalence and impact of internal discrepancies.

Palchuk MB, Fang EA, Cygielnik JM, Labreche M, Shubina M, Ramelson HZ, Hamann C, Broverman C, Einbinder JS, Turchin A.

J Am Med Inform Assoc. 2010 Jul-Aug;17(4):472-6. doi: 10.1136/jamia.2010.003335.

11.

Agreement between drugs-to-avoid criteria and expert assessments of problematic prescribing.

Steinman MA, Rosenthal GE, Landefeld CS, Bertenthal D, Kaboli PJ.

Arch Intern Med. 2009 Jul 27;169(14):1326-32. doi: 10.1001/archinternmed.2009.206.

12.

Inappropriate benzodiazepine use in older adults and the risk of fracture.

van der Hooft CS, Schoofs MW, Ziere G, Hofman A, Pols HA, Sturkenboom MC, Stricker BH.

Br J Clin Pharmacol. 2008 Aug;66(2):276-82. doi: 10.1111/j.1365-2125.2008.03185.x.

13.

Inappropriate drug prescribing in older adults: the updated 2002 Beers criteria--a population-based cohort study.

van der Hooft CS, Jong GW, Dieleman JP, Verhamme KM, van der Cammen TJ, Stricker BH, Sturkenboom MC.

Br J Clin Pharmacol. 2005 Aug;60(2):137-44.

15.

Why most interventions to improve physician prescribing do not seem to work.

Majumdar SR, Soumerai SB.

CMAJ. 2003 Jul 8;169(1):30-1. Review. No abstract available.

18.
Items per page

Supplemental Content

Support Center